Oncovin

In some countries, this medicine may only be approved for veterinary use.

In the US, Oncovin (vincristine systemic) is a member of the drug class mitotic inhibitors and is used to treat Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Anaplastic Oligodendroglioma, Cancer, Evan's Syndrome, Hodgkin's Lymphoma, Multiple Myeloma, Neuroblastoma, Non-Hodgkin's Lymphoma, Rhabdomyosarcoma and Wilms' Tumor.

US matches:

• Oncovin

Ingredient matches for Oncovin

Vincristine

Vincristine sulfate (a derivative of Vincristine) is reported as an ingredient of Oncovin in the following countries:

• Austria


• Denmark


• France


• Greece


• Ireland


• Japan


• Kenya


• Luxembourg


• Mexico


• Nigeria


• Oman


• Peru


• Serbia


• Sweden


• Switzerland


• Tanzania


• Uganda


• United Kingdom

International Drug Name Search